XJPX3154
Market cap117mUSD
Jan 17, Last price
826.00JPY
1D
-0.24%
1Q
-2.82%
Jan 2017
51.19%
IPO
501.95%
Name
Medius Holdings Co Ltd
Chart & Performance
Profile
Medius Holdings Co., Ltd. operates in the medical care industry in Japan. The company sells medical equipment, such as syringes, gauze, other necessary medical consumables, and advanced medical system; and provides repair, after-sales, and maintenance services for medical equipment to hospitals and other medical facilities. It is also involved in the sale and rental of nursing care and welfare equipment to hospitals, nursing care facilities, and general individuals; and sale and rental of on-board medical instruments for ambulance, AEDs, and other emergency supplies and equipment with high social needs. The company was formerly known as Kyowa Medical Holdings, Inc. and changed its name to Medius Holdings Co., Ltd. in October 2010. Medius Holdings Co., Ltd. was founded in 2009 and is based in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 259,789,000 8.67% | 239,054,420 7.83% | 221,694,333 -10.17% | |||||||
Cost of revenue | 257,371,376 | 212,103,210 | 196,455,061 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 2,417,624 | 26,951,210 | 25,239,272 | |||||||
NOPBT Margin | 0.93% | 11.27% | 11.38% | |||||||
Operating Taxes | 822,056 | 1,020,792 | 699,358 | |||||||
Tax Rate | 34.00% | 3.79% | 2.77% | |||||||
NOPAT | 1,595,568 | 25,930,418 | 24,539,914 | |||||||
Net income | 1,124,676 -24.92% | 1,498,008 -19.80% | 1,867,916 -9.59% | |||||||
Dividends | (482,353) | (415,781) | (457,793) | |||||||
Dividend yield | 2.42% | 2.16% | 2.19% | |||||||
Proceeds from repurchase of equity | 7,221,487 | |||||||||
BB yield | -34.47% | |||||||||
Debt | ||||||||||
Debt current | 19,969,000 | 14,972,395 | 12,335,047 | |||||||
Long-term debt | 4,031,881 | 4,661,763 | 5,567,784 | |||||||
Deferred revenue | 3,292,241 | 1,703,454 | 1,600,408 | |||||||
Other long-term liabilities | 1,786,224 | 162,572 | 224,556 | |||||||
Net debt | 5,607,858 | 3,037,493 | 3,455,517 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 1,921,509 | 1,224,486 | (3,899,003) | |||||||
CAPEX | (2,211,772) | (923,832) | (4,589,053) | |||||||
Cash from investing activities | (2,674,476) | (862,940) | (4,823,462) | |||||||
Cash from financing activities | 4,006,276 | 862,896 | 5,205,068 | |||||||
FCF | 46,731,016 | 23,820,981 | 14,602,922 | |||||||
Balance | ||||||||||
Cash | 13,661,381 | 10,362,665 | 9,151,314 | |||||||
Long term investments | 4,731,642 | 6,234,000 | 5,296,000 | |||||||
Excess cash | 5,403,573 | 4,643,944 | 3,362,597 | |||||||
Stockholders' equity | 16,894,068 | 15,901,510 | 14,637,205 | |||||||
Invested Capital | 43,585,436 | 35,038,237 | 31,913,217 | |||||||
ROIC | 4.06% | 77.46% | 89.39% | |||||||
ROCE | 4.79% | 66.45% | 69.93% | |||||||
EV | ||||||||||
Common stock shares outstanding | 22,051 | 21,999 | 21,936 | |||||||
Price | 905.00 3.43% | 875.00 -8.38% | 955.00 -5.82% | |||||||
Market cap | 19,956,511 3.68% | 19,248,924 -8.11% | 20,948,530 -5.85% | |||||||
EV | 25,564,369 | 22,286,417 | 24,404,047 | |||||||
EBITDA | 4,234,489 | 28,621,998 | 26,405,379 | |||||||
EV/EBITDA | 6.04 | 0.78 | 0.92 | |||||||
Interest | 99,362 | 84,937 | 68,582 | |||||||
Interest/NOPBT | 4.11% | 0.32% | 0.27% |